POSITIVE SEQUENCE BIOLOGY
Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.
POSITIVE SEQUENCE BIOLOGY
Industry:
Biopharma Biotechnology Genetics
Founded:
2020-08-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.correctsequence.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
340 M CNY
Technology used in webpage:
Euro CrUX Dataset Pound Sterling CrUX Top 10m Japanese Yen
Similar Organizations
Alix Ventures
Alix Ventures: Driving Patient Impact - Supporting Early Stage Startups Engineering Biology to Drive Radical Advances in Human Health
Azenta Life Sciences
Azenta Life Sciences provides life sciences solutions.
Cellect Biotechnology
Cellect Biotechnology is a biotechnology company engaged in developing a novel technology platform.
Drug Farm
Drug Farm is a biotechnology company utilizing genetics and AI technologies to discover and develop innovative, immune-modulating therapies.
Genzyme
Genzyme Corporation (Genzyme) is a biotechnology company. The Company's product and service portfolio is focused on rare genetic disease
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
InventisBio
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Silenseed
Silenseed is a biopharmaceutical company that focuses on the development of cancer therapies.
Current Employees Featured
Founder
Investors List
Boyu Capital
Boyu Capital investment in Series A - Positive Sequence Biology
Lilly Asia Ventures
Lilly Asia Ventures investment in Series A - Positive Sequence Biology
New Alliance Capital
New Alliance Capital investment in Series A - Positive Sequence Biology
Sequoia Capital China
Sequoia Capital China investment in Series A - Positive Sequence Biology
TF Capital
TF Capital investment in Series A - Positive Sequence Biology
Zoo Capital
Zoo Capital investment in Series A - Positive Sequence Biology
Sequoia Capital China
Sequoia Capital China investment in Angel Round - Positive Sequence Biology
Official Site Inspections
http://www.correctsequence.com
- Host name: 101.132.179.73
- IP address: 101.132.179.73
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Positive Sequence Biology"
About Us-正序生物 - correctsequence.com
正序生物（CorrectSequence Therapeutics）是一家专注于新型基因编辑技术的生物医药公司，利用世界先进的碱基编辑体系，为罹患严重疾病的人们开发突破性精准基因编辑疗法，造福人类 …See details»
正序生物官网
2024-10-10. 10月12日，正序生物科学创始人陈佳教授及上科大生命教师团队微电影登上上海教育电视台！ 查看详情See details»
公司介绍-正序生物 - correctsequence.com
正序生物（CorrectSequence Therapeutics）是一家专注于新型基因编辑技术的生物医药科技公司，利用世界先进的碱基编辑体系，为罹患严重疾病的人们开发突破性精准基因编辑疗法，造福 …See details»
CorrectSequence Therapeutics Co., Ltd. - Drug pipelines, Patents ...
CorrectSequence Therapeutics (Correctseq) was established in August 2020 and is located in Shanghai, China. The company was founded by a team of four individuals, including Dr. Jia …See details»
CorrectSequence Therapeutics - LinkedIn
CorrectSequence Therapeutics (Correctseq) is a clinical-stage biotech company employing its proprietary transformer base editing (tBE) technology to pioneer next-generation gene editing …See details»
CorrectSequence Therapeutics - Crunchbase Company Profile
Organization. CorrectSequence Therapeutics . Connect to CRM . Save . Summary. Financials. People. Signals & News. ... CorrectSequence Therapeutics closed its last funding round on …See details»
The World’s First Clinical Base Editing Therapy for …
SHANGHAI — On January 8, 2024, Shanghai, China, CorrectSequence Therapeutics Co., Ltd. (), using innovative transformer Base Editing (tBE) technology to help people with severe …See details»
The World's First Clinical Base Edting Therapy for Hemoglobinopathy
On January 8, 2024, Shanghai,China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), using innovative transformer Base Editing (tBE) technology to help people with severe …See details»
Positive Sequence Biology - Crunchbase Company Profile & Funding
Organization. Positive Sequence Biology . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
正序生物官网 - correctsequence.com
Jia Chen, Co-founder of CorrectSequence Therapeutics to Participate in the 5th International Conference on Base Editing, Prime Editing & Related Enzymes. More. 2024-01-08. The …See details»
The World's First Clinical Base Editing Therapy for …
Jan 8, 2024 CorrectSequence Therapeutics' CS-101 Successfully Cures One Patient of Transfusion-Dependent β-Thalassemia. SHANGHAI, Jan. 8, 2024 /PRNewswire/ -- On …See details»
The World’s First Clinical Base Editing Therapy for ... - BioSpace
Jan 8, 2024 CorrectSequence Therapeutics’ CS-101 Successfully Cures One Patient of Transfusion-Dependent β-Thalassemia On January 8, 2024, Shanghai, China, …See details»
OBiO Technology Congratulates on The First Clinical Gene Editing ...
Aug 5, 2024 CorrectSequence Therapeutics TM ... Established in 2013, OBiO Technology is a pioneering Contract Research Organization (CRO) and Contract Development and …See details»
OBiO Technology Congratulates on The First Clinical Gene Editing ...
Aug 6, 2024 CorrectSequence Therapeutics TM (Correctseq TM), is a clinical-stage biotech company employing its proprietary transformer Base Editor (tBE) to pioneer next-generation …See details»
OBiO Technology Congratulates on The First Clinical Gene Editing ...
Aug 6, 2024 Recently, CorrectSequence Therapeutics Co., Ltd. (Correctseq) announced a significant milestone in their base editing therapy CS-101 for transfusion-dependent β …See details»
The World's First Clinical Base Editing Therapy for …
SHANGHAI, Jan. 8, 2024 /PRNewswire/ -- On January 8, 2024, Shanghai,China, CorrectSequence Therapeutics Co., Ltd. , using innovative transformer Base Editing (tBE) …See details»
OBiO Technology Congratulates on The First Clinical Gene
SHANGHAI, Aug. 5, 2024 /PRNewswire/ -- Recen tly, CorrectSequence Therapeutics Co., Ltd. (Correctseq) announced a significant milestone in their base editing therapy CS-101 for …See details»
The World’s First Clinical Base Editing Therapy for …
Jan 8, 2024 CorrectSequence Therapeutics’ CS-101 Successfully Cures One Patient of Transfusion-Dependent β-Thalassemia On January 8, 2024, Shanghai, China, …See details»
Dr. Xiaodun Mou Joins CorrectSequence Therapeutics as CEO
CorrectSequence Therapeutics (Correctseq), founded in 2020, has announced the appointment of Dr. Xiaodun (Susan) Mou as the Chief Executive Officer (CEO), in charge of general operation …See details»
CS-101 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 CorrectSequence Therapeutics’ CS-101 Successfully Cures One Patient of Transfusion-Dependent β-Thalassemia On January 8, 2024, Shanghai, China, …See details»